Evidence map›Paper›PMID 33617602›Full record

ArticlePLoS pathogens2021

Effector memory CD8 T cell response elicits Hepatitis E Virus genotype 3 pathogenesis in the elderly.

Hicham El Costa, Jordi Gouilly, Florence Abravanel, Elmostafa Bahraoui, Jean-Marie Peron, Nassim Kamar, Nabila Jabrane-Ferrat, Jacques Izopet

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Hepatitis E virus: from innate sensing to adaptive immune responses.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  6. Review
  7. Bystander activated CD8Nature communications · 2024
    Article
  8. IL-15-induced CD38Clinical & translational immunology · 2024
    Article
  9. Article
  10. Immunobiology and Host Response to HEV.Advances in experimental medicine and biology · 2023
    Article
  11. Article
  12. Review
  13. Nosocomial transmission of hepatitis E virus and development of chronic infection: The wider impact of COVID-19.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2022
    Article
  14. Hepatitis E Virus Immunopathogenesis.Pathogens (Basel, Switzerland) · 2021
    Review
  15. Review
  16. Review
  17. Assessment of hepatitis E seropositivity among HIV-infected patients in Bulgaria.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hicham El CostaInfinity-Université Toulouse, CNRS, Inserm, Toulouse, France.ORCID 0000-0001-8889-9759
Jordi GouillyInfinity-Université Toulouse, CNRS, Inserm, Toulouse, France.ORCID 0000-0001-8684-7429
Florence AbravanelInfinity-Université Toulouse, CNRS, Inserm, Toulouse, France.ORCID 0000-0002-1753-1065
Elmostafa BahraouiInfinity-Université Toulouse, CNRS, Inserm, Toulouse, France.
Jean-Marie PeronDépartement de Gastroentérologie, CHU Toulouse, Toulouse, France.
Nassim KamarInfinity-Université Toulouse, CNRS, Inserm, Toulouse, France.ORCID 0000-0003-1930-8964
Nabila Jabrane-FerratInfinity-Université Toulouse, CNRS, Inserm, Toulouse, France.ORCID 0000-0003-4809-7836
Jacques IzopetInfinity-Université Toulouse, CNRS, Inserm, Toulouse, France.
Centre National de la Recherche Scientifique · FRCentre Hospitalier Universitaire de Toulouse · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genotype 3 Hepatitis E virus (HEV-3) is an emerging threat for aging population. More than one third of older infected patients develops clinical symptoms with severe liver damage, while others remain asymptomatic. The origin of this discrepancy is still elusive although HEV-3 pathogenesis appears to be immune-mediated. Therefore, we investigated the role of CD8 T cells in the outcome of the infection in immunocompetent elderly subjects. We enrolled twenty two HEV-3-infected patients displaying similar viral determinants and fifteen healthy donors. Among the infected group, sixteen patients experienced clinical symptoms related to liver disease while six remained asymptomatic. Here we report that symptomatic infection is characterized by an expansion of highly activated effector memory CD8 T (EM) cells, regardless of antigen specificity. This robust activation is associated with key features of early T cell exhaustion including a loss in polyfunctional type-1 cytokine production and partial commitment to type-2 cells. In addition, we show that bystander activation of EM cells seems to be dependent on the inflammatory cytokines IL-15 and IL-18, and is supported by an upregulation of the activating receptor NKG2D and an exuberant expression of T-Bet and T-Bet-regulated genes including granzyme B and CXCR3. We also show that the inflammatory chemokines CXCL9-10 are increased in symptomatic patients thereby fostering the recruitment of highly cytotoxic EM cells into the liver in a CXCR3-dependent manner. Finally, we find that the EM-biased immune response returns to homeostasis following viral clearance and disease resolution, further linking the EM cells response to viral burden. Conversely, asymptomatic patients are endowed with low-to-moderate EM cell response. In summary, our findings define immune correlates that contribute to HEV-3 pathogenesis and emphasize the central role of EM cells in governing the outcome of the infection.

Indexed as

AgedCase-Control StudiesCD8-Positive T-LymphocytesCytokinesFemaleGenotypeHepatitis EHepatitis E virusHumansImmunologic MemoryMaleMiddle AgedReceptors, CXCR3CXCR3 protein, humanCytokinesReceptors, CXCR3

Identifiers

PMID33617602
PMCPMC7932504
OpenAlexW3132949271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.